As prescription drug prices continue to be a top public concern, Axios features results from GoodRx's survey covering the impact of prescription drug prices and consumer behavior.
Read More
Doug Hirsch, GoodRx Co-CEO and founder, shares what it means to him to be a CEO after 7 years since launching GoodRx.
Read More
Spectrum Equity originally invested in GoodRx in 2015 and will remain an investor and board member to continue to support the GoodRx management team post the Silver Lake investment.
Read More
GoodRx's partner website, Iodine, won the Webby for the Best Health Website, based on votes from a 2,000+ member judging body. GoodRx previously won the Webby in 2012.
Read More
The GoodRx and Allscripts partnership empowers providers in addressing prescription affordability at the time the medication is prescribed.
Read More
GoodRx has partnered with Asembia, a network of specialty pharmacies, in order to support the unique needs of specialty pharmacy patients, who often require additional prescription information.
Read More
GoodRx will provide DentalPlans.com patients with an area's lowest medication prices in order to help prescription adherence and better health outcomes.
Read More
Iodine’s high-quality content and SEO relevance will be additive to several of GoodRx’s key marketing and product initiatives.
Read More
The partnership will provide manufacturer prescription co-pay savings coupons to GoodRx's five million unique monthly visitors.
Read More
The partnership provides the first compound pharmacy cash discount card program, a pricing information and discounts service on a class of medications that accounts for more than $2B in annual sales.
Read More
CEO Doug Hirsch answers FAQs and shares how GoodRx helps consumers to be savvier and save money on prescription drugs.
Read More
As featured in the New York Times, most major pharmacies do not list the price of the drugs they sell, but GoodRx is making pricing information more transparent.
Read More
GoodRx, the leading online platform to access, compare and transact on discounted prescription drug prices, receives a growth investment from Francisco Partners and Spectrum Equity.
Read More